Literature DB >> 22005070

Antioxidants in the canine model of human aging.

Amy L S Dowling1, Elizabeth Head.   

Abstract

Oxidative damage can lead to neuronal dysfunction in the brain due to modifications to proteins, lipids and DNA/RNA. In both human and canine brain, oxidative damage progressively increases with age. In the Alzheimer's disease (AD) brain, oxidative damage is further exacerbated, possibly due to increased deposition of beta-amyloid (Aβ) peptide in senile plaques. These observations have led to the hypothesis that antioxidants may be beneficial for brain aging and AD. Aged dogs naturally develop AD-like neuropathology (Aβ) and cognitive dysfunction and are a useful animal model in which to test antioxidants. In a longitudinal study of aging beagles, a diet rich in antioxidants improved cognition, maintained cognition and reduced oxidative damage and Aβ pathology in treated animals. These data suggest that antioxidants may be beneficial for human brain aging and for AD, particularly as a preventative intervention. This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005070      PMCID: PMC3291812          DOI: 10.1016/j.bbadis.2011.09.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  116 in total

1.  Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques.

Authors:  N Papaioannou; P C Tooten; A M van Ederen; J R Bohl; J Rofina; T Tsangaris; E Gruys
Journal:  Amyloid       Date:  2001-03       Impact factor: 7.141

2.  Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

Authors:  K H Masaki; K G Losonczy; G Izmirlian; D J Foley; G W Ross; H Petrovitch; R Havlik; L R White
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

3.  A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

Authors:  L J Thal; M Calvani; A Amato; A Carta
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

Review 4.  Protein oxidation in aging, disease, and oxidative stress.

Authors:  B S Berlett; E R Stadtman
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

Review 5.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

6.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

7.  Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.

Authors:  Stuart A Montgomery; L J Thal; R Amrein
Journal:  Int Clin Psychopharmacol       Date:  2003-03       Impact factor: 1.659

8.  Dietary patterns and risk of dementia: the Three-City cohort study.

Authors:  P Barberger-Gateau; C Raffaitin; L Letenneur; C Berr; C Tzourio; J F Dartigues; A Alpérovitch
Journal:  Neurology       Date:  2007-11-13       Impact factor: 9.910

9.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors:  Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Neurol       Date:  2004-01

Review 10.  The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches.

Authors:  Carl W Cotman; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

View more
  5 in total

1.  An Antioxidant Dietary Supplement Improves Brain-Derived Neurotrophic Factor Levels in Serum of Aged Dogs: Preliminary Results.

Authors:  Sara Sechi; Francesca Chiavolelli; Nicoletta Spissu; Alessandro Di Cerbo; Sergio Canello; Gianandrea Guidetti; Filippo Fiore; Raffaella Cocco
Journal:  J Vet Med       Date:  2015-06-23

2.  A Frailty Index based on clinical data to quantify mortality risk in dogs.

Authors:  Tommaso Banzato; Giovanni Franzo; Roberta Di Maggio; Elisa Nicoletto; Silvia Burti; Matteo Cesari; Marco Canevelli
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

3.  Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain.

Authors:  G P Swain; M Prociuk; J H Bagel; P O'Donnell; K Berger; K Drobatz; B L Gurda; M E Haskins; M S Sands; C H Vite
Journal:  Gene Ther       Date:  2013-10-17       Impact factor: 5.250

4.  Evidence supporting the conceptual framework of cancer chemoprevention in canines.

Authors:  Tamara P Kondratyuk; Julie Ann Luiz Adrian; Brian Wright; Eun-Jung Park; Richard B van Breemen; Kenneth R Morris; John M Pezzuto
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

Review 5.  Improving Age-Related Cognitive Decline through Dietary Interventions Targeting Mitochondrial Dysfunction.

Authors:  Aleksandra Kaliszewska; Joseph Allison; Matteo Martini; Natalia Arias
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.